The Approval Process in Action

Source: The Life Sciences Report and Visual Capitalist (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

For news on how catalysts affect specific stocks, read the updated Life Sciences Report Watchlist.

DarioHealth (DRIO) Expands Reach via Beluga Health Deal
Source: Streetwise Reports (07/01/2026)

DarioHealth (DRIO) integrates its AI platform with Beluga Health's network to scale provider-backed care. Discover growth catalysts, analyst targets, and investor considerations.

Cosa Resources Advances Partner-Funded Uranium Surveys
Source: Streetwise Reports (07/01/2026)

Cosa Resources launches partner-backed radiometric and ANT surveys at Aurora and Astro uranium projects. Learn why this Athabasca Basin explorer offers retail investors reduced-risk exposure to rising long-term uranium demand.

enCore Energy Secures 20-Year NRC License for Dewey Burdock Uranium
Source: Streetwise Reports (07/01/2026)

enCore Energy advances Dewey Burdock ISR uranium project after 20-year NRC license renewal. Explore sector timing, analyst views, permitting catalysts, and investment considerations for retail investors.

Grande Portage Resources Secures Major Ocean Partners Deal
Source: Streetwise Reports (07/01/2026)

Grande Portage Resources advances New Amalga gold project with Ocean Partners offtake, CA$6M equity, and US$25M loan. Discover the strategic financing and development timeline for retail investors.

Rio2 Ltd. Gains Strong Copper Exposure via Condestable Acquisition
Source: Streetwise Reports (07/01/2026)

Rio2 Ltd. secures immediate cash flow and a 14-year mine life at Condestable. Discover how the copper-gold-silver operation positions the company amid surging AI-driven demand.